News Flagship joins three biotechs together to form Etcelera Flagship Pioneering has formed a new AI-focused biotech company, called Etcelera, by combining the platforms of three firms from its portfolio.
News Dren Bio pockets $350m for rare blood cancer programme Dren Bio has closed a sizeable private financing round, raising $350m for pivotal trials of a possible first-in-class therapy for rare blood cancers.
News US gives $99m for Ebola jab project, as cases spread in Afri... As Africa's CDC chief warns "unprecedented" Ebola outbreak could spread to other parts of the world, the US awards R&D funding to an IAVI vaccine.
News Lilly's tirzepatide juggernaut is still gathering momentum Lilly shrugs off concerns about the effect of US drug pricing policies on its diabetes and weight loss drugs as revenues leap 39% to $24.4bn.
News Oura smart ring to be used in weight-loss outcomes trial Oura has launched a trial to see if data collected from its smart rings can help scientists understand physiological changes with obesity treatment.
News HHS doubles down on controversial peptides plan HHS unveils an enforcement holiday to manufacture of unapproved peptides - before the FDA decides if they should be allowed in compounded medicines.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.